SAFAfine

N/A

Report date: 2025/01/26 17:50:55

Base Information

Drug NameSAFAfine

Drug Alias NameRecombinant factor IX (Aprilbio)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCoagulation factor IX stimulants

TargetsCoagulation factor IX

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAprilBio Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAprilBio Co Ltd

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeN/A